1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow GNT Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rescues On Reperfusion Damage In Cerebral Infarction by Nelonemdaz Neu2000KWL group, Placebo group - Ischemic Stroke | Phase 3 | Unknown | GNT Pharma | 496 | 2021-12-25 | 2022-09-26 |
Ischemic Stroke (1)
South Korea (1)